Towada Products · New Delhi, India · Last updated:
Azacitidine is a hypomethylating agent used for myelodysplastic syndromes, chronic myelomonocytic leukaemia and acute myeloid leukaemia. Towada Products exports it from New Delhi, India, supplying Azadual in the 100mg strength to licensed buyers in Southeast Asia, the CIS region, the Middle East and select markets in Europe and Africa. Pricing is on enquiry.
Azacitidine is a pyrimidine nucleoside analogue and hypomethylating agent. It is built into RNA and DNA and inhibits DNA methyltransferase, which can switch back on genes that control normal blood cell maturation, and it is also directly toxic to abnormal blood-forming cells.
Injectable azacitidine is approved for myelodysplastic syndromes, in Europe specifically for intermediate-2 and high-risk disease in adults not eligible for stem cell transplantation; for chronic myelomonocytic leukaemia; and for acute myeloid leukaemia in older adults not eligible for transplantation. In the United States it is also approved for juvenile myelomonocytic leukaemia. The originator brand is Vidaza. A separate oral tablet (Onureg) has its own approval for AML maintenance and is not interchangeable.
Our catalog lists azacitidine 100mg powder for injection, given subcutaneously or intravenously in hospital and handled under cytotoxic safe-handling procedures. Haematology departments are the main buyers. The unopened vials are kept at room temperature. State the quantity when you enquire.
Azacitidine is a prescription medicine, and whether it is suitable for a patient is a decision for the treating doctor. This page describes the medicine for trade buyers; it is not medical advice.
Every azacitidine product page on this site. "Listed for" is the use given in our catalog. Availability is confirmed when you enquire.
| Product | Composition | Listed for |
|---|---|---|
| Azadual 100mg | Azacitidine (100mg) | Treatment of Myelodysplastic syndrome |
Export markets we serve: Southeast Asia, the CIS region, the Middle East and select markets in Europe and Africa. See our export markets →
Tell us which documents your regulator or customs broker needs and we will confirm what applies to the product you are ordering.
Azacitidine is a hypomethylating agent used for myelodysplastic syndromes, chronic myelomonocytic leukaemia and acute myeloid leukaemia. It is a prescription medicine, and whether it is suitable for a patient is a decision for the treating doctor.
Our catalog has 1 azacitidine product page in the 100mg strength, from 1 brand: Azadual. The table on this page links to each product page; availability is confirmed when you enquire.
We ship from New Delhi by international courier or air cargo to licensed buyers in Southeast Asia, the CIS region, the Middle East and select markets in Europe and Africa, and have country pages for the Philippines, Russia, Kazakhstan, Uzbekistan, Iraq, Saudi Arabia and Brazil. Whether azacitidine can be imported, and by whom, is decided by the destination country's medicines regulator, so tell us the country and we will confirm what is possible. Every country we cover is listed on our export markets page.
Each shipment travels with a commercial invoice, a packing list and a courier or air waybill. We provide a Certificate of Analysis (CoA) for the batch and, where it is available for the product and the destination country requires it, a Certificate of Pharmaceutical Product (CoPP). A certificate of origin can be arranged on request.
Use the enquiry form on this page, WhatsApp +91 99995 62955 or email H.S.Gandhi@towadaproducts.in. Tell us the brand, strength, quantity and destination country, and we will reply with availability and a formal quotation.
This page is general information for trade buyers. It is not medical advice. Import rules differ by country and change over time; confirm the current requirements with your national medicines regulator before ordering.
Tell us the brand, strength, quantity and destination country. Pricing is confirmed in a formal quote. Prefer WhatsApp? Message +91 99995 62955.
Plain answers to the questions importers ask before ordering medicines from India.
